Aditya Birla Sunlife Life Pharma & Healthcare Fund Normal Dividend Reinvestment

Equity Create Wealth
Sectoral Fund - Pharma & Health Care
Category Rank
Aditya Birla Sunlife Life Pharma & Healthcare Fund Normal Dividend Reinvestment
Rating
Fund
Time to Invest
Aditya Birla Sunlife Life Pharma & Healthcare Fund Normal Dividend Reinvestment
NAV
10.09
(15/10/2019)
L 52Wk H
9.72
10.40
Login using to know what your Friends are Investing !

Aditya Birla Sunlife Life Pharma & Healthcare Fund Normal Dividend Reinvestment

Equity
Sectoral Fund - Pharma & Health Care
Create Wealth
Rank Aditya Birla Sunlife Life Pharma & Healthcare Fund Normal Dividend Reinvestment
Fund
NAV
10.09
(15/10/2019)
Time to Invest
Aditya Birla Sunlife Life Pharma & Healthcare Fund Normal Dividend Reinvestment
Rating
L 52Wk H
9.72
10.40
Investment Objective

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved. .

Category
  • Equity - Sectoral Fund - Pharma & Health Care
Benchmark
  • S&P BSE Health Care - TRI
Returns
1M
-2.79%
3M
-0.59%
6M
-
1Y
-
3Y
-
5Y
-
Historical NAV
NAV for scheme Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Dividend Reinvest is
Growth of 10,000
An investment of 10000 for in this scheme would have grown to Rs.

Risk of the fund

Aditya Birla Sunlife Life Pharma & Healthcare Fund Normal Dividend Reinvestment

AUM

160.30 Cr
Aditya Birla Sunlife Life Pharma & Healthcare Fund Normal Dividend Reinvestment AUM is 75% lower than other schemes in the category

Load

Entry Load - NIL
Exit Load - 0.50% on or before 90D Nil after 90D
Lock In Period - NIL

Expense Ratio

2.71%
Aditya Birla Sunlife Life Pharma & Healthcare Fund Normal Dividend Reinvestment Expense Ratio is 85% lower than other schemes in the category

Turnover Ratio

9.00%
Aditya Birla Sunlife Life Pharma & Healthcare Fund Normal Dividend Reinvestment Turnover Ratio is 83% lower than other schemes in the category